Skip to Content

180 Life Sciences Corp Ordinary Shares ATNF

Morningstar Rating
$3.33 +0.10 (2.94%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

ATNF is trading at a 46% discount.
Price
$3.21
Fair Value
$9.88
Uncertainty
Extreme
1-Star Price
$16.12
5-Star Price
$3.27
Economic Moat
Vkvfjwx
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if ATNF is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$3.23
Day Range
$3.233.42
52-Week Range
$2.8555.10
Bid/Ask
$3.26 / $3.39
Market Cap
$1.93 Mil
Volume/Avg
14,563 / 38,407

Key Statistics

Price/Earnings (Normalized)
0.68
Price/Sales
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

180 Life Sciences Corp is a clinical-stage biotechnology company. It is focused on the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain by leveraging the combined expertise of luminaries in therapeutics.
Sector
Healthcare
Industry
Biotechnology
Stock Style Box
Small Value
Total Number of Employees
5

Valuation

Metric
ATNF
Price/Earnings (Normalized)
0.68
Price/Book Value
Price/Sales
Price/Cash Flow
Price/Earnings
ATNF

Financial Strength

Metric
ATNF
Quick Ratio
0.58
Current Ratio
0.70
Interest Coverage
−1,110.59
Quick Ratio
ATNF

Profitability

Metric
ATNF
Return on Assets (Normalized)
−9.43%
Return on Equity (Normalized)
−16.14%
Return on Invested Capital (Normalized)
−14.73%
Return on Assets
ATNF
See how this stock stacks up to its competitors with Morningstar Investor

Biotechnology Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Economic Moat
Market Cap
NVO
Novo Nordisk A/S ADRRklks$550.4 Bil
VRTX
Vertex Pharmaceuticals IncGmbhmwy$111.8 Bil
REGN
Regeneron Pharmaceuticals IncJpfnbg$107.9 Bil
MRNA
Moderna IncNbps$36.3 Bil
ARGX
argenx SE ADRYjcqk$23.0 Bil
BNTX
BioNTech SE ADRHtbb$21.6 Bil
ALNY
Alnylam Pharmaceuticals IncDsngrm$19.2 Bil
BMRN
Biomarin Pharmaceutical IncZzkpys$16.4 Bil
RPRX
Royalty Pharma PLC Class AWkzsgc$13.4 Bil
INCY
Incyte CorpZlyzhx$13.3 Bil

Sponsor Center